Cargando…
Feasibility of high-dose tadalafil and effects on insulin resistance in well-controlled patients with type 2 diabetes (MAKROTAD): a single-centre, double-blind, randomised, placebo-controlled, cross-over phase 2 trial
BACKGROUND: Phosphodiesterase-5 inhibitors exert positive vascular and metabolic effects in type 2 diabetes (T2D), but the effect on insulin resistance in T2D is unclear. METHODS: This randomised, double blind, placebo-controlled, two-period crossover trial was conducted at Sahlgrenska University Ho...
Autores principales: | Fryk, Emanuel, Rodrigues Silva, Vagner Ramon, Bauzá-Thorbrügge, Marco, Schmelz, Martin, Gan, Li-Ming, Strindberg, Lena, Jansson, Per-Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225663/ https://www.ncbi.nlm.nih.gov/pubmed/37256099 http://dx.doi.org/10.1016/j.eclinm.2023.101985 |
Ejemplares similares
-
Hyperinsulinemia and insulin resistance in the obese may develop as part of a homeostatic response to elevated free fatty acids: A mechanistic case-control and a population-based cohort study
por: Fryk, Emanuel, et al.
Publicado: (2021) -
Galectin-1 in Obesity and Type 2 Diabetes
por: Fryk, Emanuel, et al.
Publicado: (2022) -
Galectin-1 is inversely associated with type 2 diabetes independently of obesity – A SCAPIS pilot study()
por: Fryk, Emanuel, et al.
Publicado: (2019) -
The role of the platelet pool of Plasminogen Activator Inhibitor-1 in well-controlled type 2 diabetes patients
por: Mossberg, Karin, et al.
Publicado: (2022) -
Tadalafil increases muscle capillary recruitment and forearm glucose uptake in women with type 2 diabetes
por: Jansson, P.-A., et al.
Publicado: (2010)